Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06755047

3D Placental Volume in Placenta Accreta

Placenta Accreta spectrum is a major obstetric disease nowadays. Different methods are used for antenatal diagnosis. In our study, investigators are aiming to compare 2 common ways for diagnosis, i.e; 3D Ultrasound and 2D with color Doppler.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Placenta Accreta Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Placenta Diseases Pregnancy Complications Urogenital Diseases

Sex eligibility

Female

Study type

Observational

Primary location

Women's Health Hospital

Asyut, Egypt

Location status: Recruiting

Location contact

Mohamed Fekry, Lecturer

CONTACT

[email protected]

0882312388

About this study

The word placenta accreta spectrum disorders (PASD) implies an atypical implantation of the placenta into the uterine wall and has been used to express placenta accreta, increta and percreta. Placenta accreta is a placenta where the placental villi sick on directly to the myometrium. Placenta increta is a placenta where the placental villi attack into the myometrium and placenta percreta is a placenta where the villi invade through the myometrium and into serosa. No antenatal diagnostic method gives the clinician 100% assurance of either ruling in or ruling out the existence of placenta accreta. The definitive diagnosis of placental accreta spectrum is frequently ended postpartum on hysterectomy specimens when an area of accretion shows chorionic villi which make direct contact with the myometrium and absence of deciduae. Antenatal ultrasound is the method of choice used to establish the diagnosis and direct clinical management.The combined use of power Doppler with three dimensional (3D) ultrasound provides the possibility of quantifying moving blood within a volume of interest. Three indices are calculated, namely vascularization index (VI), flow index and vascularization flow index

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pregnant women with placenta previa

Exclusion criteria

  • congenital anomalies of placenta Placental separation Uterine anomalies

Treatment and study plan

3D ultrasound

Radiation

3D placental volume and vascular indices

2D ultrasound

Radiation

2D placental criteria of invasion and color Doppler

Primary outcomes

  1. Vascular index

    Time frame: 1 months

    3D Vascularization index

Secondary outcomes

  1. 2D ultrasound

    Time frame: 1 months

    myometrial thinning (>1mm),

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed Fekry, PhD

CONTACT

[email protected]

0882312

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

3D Ultrasound Placental Volume and Vascular Indices Versus 2D Parameters for Diagnosis of Placenta Accreta Spectrum

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 1, 2025
Registry last updated
Jan 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.